CoChat

Caspofungin Use in Patients with Invasive Candidiasis Caused by Common Non- albicans Candida Species: Review of the Caspofungin Database

Open access
Colombo, Arnaldo L., Ngai, Angela L., Bourque, Michael, Bradshaw, Susan K., Strohmaier, Kim M., Taylor, Arlene F., Lupinacci, Robert J., Kartsonis, Nicholas A. · 2010 · Antimicrobial Agents and Chemotherapy
Cited by 41

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Increasing rates of invasive candidiasis caused by non- albicans Candida species have been reported worldwide. Particular concerns have been raised for C. parapsilosis because of reduced in vitro susceptibility to echinocandins. We identified 212 patients with invasive candidiasis due to non- albicans Candida species (≥5 cases per species) in 5 clinical trials of caspofungin monotherapy from the pharmaceutical sponsor's (Merck and Co., Inc.) database: 71 cases were caused by C. parapsilosis , 65 by C. tropicalis , 54 by C. glabrata , 10 by C. krusei , 9 by C. guilliermondii , and 5 by C. lusitaniae . One hundred sixty-seven cases caused by C. albicans were also identified. Efficacy was assessed at the end of caspofungin therapy. Success (favorable overall response) required favorable clinical and microbiological responses. The mean APACHE II scores were 16.5 in the non- albicans group and 15.7 in the C. albicans group. Neutropenia at study entry was more common in the non- albicans group (12%) than in the C. albicans group (5%). The median duration of caspofungin therapy was 14 days in both groups. The success rates were 77% in both groups and at least 70% for each non- albicans species: 74% for C. parapsilosis , 71% for C. tropicalis , 85% for C. glabrata , 70% for C. krusei , 89% for C. guilliermondii , and 100% for C. lusitaniae . The times to negative blood culture were similar for the various species. The overall mortality rates were 26% in the non- albicans group and 29% in the C. albicans group. Drug-related serious adverse events and discontinuations due to caspofungin toxicity were uncommon. Although the sample sizes were limited, caspofungin demonstrated favorable efficacy and safety profiles in the treatment of invasive candidiasis caused by the following non- albicans Candida species: C. parapsilosis , C. tropicalis , C. glabrata , C. krusei , C. guilliermondii , and C. lusitaniae .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.00911-09

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 41

Metadata

Authors
Colombo, A. L., Ngai, A. L., Bourque, M., Bradshaw, S. K., Strohmaier, K. M., Taylor, A. F., Lupinacci, R. J., & Kartsonis, N. A.
Venue
Antimicrobial Agents and Chemotherapy
Published
2010-05
Volume
54
Issue
5
Pages
1864-1871
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2139051460
Cited by
41
References
5
FWCI
4.23
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Caspofungin Use in Patients with Invasive Candidiasis Caused by Common Non- albicans Candida Species: Review of the Caspofungin Database. https://app.cochat.ai/papers/10.1128/aac.00911-09
The paper
Colombo, A. L., Ngai, A. L., Bourque, M., Bradshaw, S. K., Strohmaier, K. M., Taylor, A. F., Lupinacci, R. J., & Kartsonis, N. A. (2010). Caspofungin Use in Patients with Invasive Candidiasis Caused by Common Non- albicans Candida Species: Review of the Caspofungin Database. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00911-09

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.